株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

使い捨てバイオリアクターの世界市場 2021年までの予測:製品 (幹細胞、インターフェロン)・細胞・技術・用途・エンドユーザー別

Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 318616
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
使い捨てバイオリアクターの世界市場 2021年までの予測:製品 (幹細胞、インターフェロン)・細胞・技術・用途・エンドユーザー別 Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021
出版日: 2016年10月04日 ページ情報: 英文 151 Pages
概要

世界の使い捨てバイオリアクター (生物反応器) の市場規模は、2016年の4億840万米ドルの規模から、21.6%もの年平均成長率 (CAGR) で成長し、2021年には10億8570万米ドルに達する見込みとなっています。この市場の成長を促す主な要因としては、小企業・新設企業での投資収益率 (ROI) 改善効果や、自動化における複雑化の回避、環境へのプラスの影響などが挙げられます。技術別に見ると、柔軟性の高さやリードタイムの短さから、波誘発動バイオリアクターが最大のシェアを占めています。地域別では、欧州が世界最大の市場となる一方、今後の市場成長率はアジア太平洋地域が最大となっています。

当レポートでは、世界の使い捨てバイオリアクター (SUB) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、製品別・細胞別・技術別・用途別・エンドユーザー別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 使い捨てバイオリアクターの世界市場:概要

  • イントロダクション
  • 市場動態
    • 市場発展促進要因
      • 小規模企業・新興企業でのSUBの導入増加
      • 自動化における複雑さの緩和
      • 海洋生物 (藻類) 培養の簡素化
      • 環境への影響の軽減
    • 市場発展阻害要因
      • 使い捨てバイオリアクターの関連規制への懸念
      • 漏出物および抽出物に関する問題
    • 市場機会
      • 生物製剤
      • 生物製剤市場の成長
      • 特許満了
    • 課題
      • 柔軟なバイオリアクターに関する制約
      • 使い捨てセンサーの機能向上ニーズ

第6章 使い捨てバイオリアクターの世界市場:産業動向

  • 産業動向
  • サプライチェーン分析
  • PESTEL分析 (政治的・経済的・社会的・技術的・環境的・法的要因)

第7章 使い捨てバイオリアクターの世界市場:製品タイプ別

  • イントロダクション
  • モノクローナル抗体 (MAb)
  • ワクチン
  • 遺伝子組み換えタンパク質
  • 幹細胞
  • 遺伝子組み換え細胞
  • その他の製品

第8章 使い捨てバイオリアクターの世界市場:細胞タイプ別

  • イントロダクション
  • 哺乳類細胞
  • 細菌性細胞
  • 酵母細胞
  • その他

第9章 使い捨てバイオリアクターの世界市場:技術別

  • イントロダクション
  • 波誘発動使い捨てバイオリアクター
  • 攪拌槽使い捨てバイオリアクター
  • 使い捨て気泡塔バイオリアクター
  • その他の技術

第10章 使い捨てバイオリアクターの世界市場:用途別

  • イントロダクション
  • バイオプロダクション
  • プロセス開発
  • 研究開発 (R&D)

第11章 使い捨てバイオリアクターの世界市場:エンドユーザー別

  • イントロダクション
  • バイオ医薬品メーカー
  • 研究開発 (R&D) 部門

第12章 使い捨てバイオリアクターの世界市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • その他
  • アジア太平洋地域
  • 他の国々 (RoW)

第13章 競合情勢

  • 概要
  • 競争状況と動向
    • 新製品発表
    • 買収
    • 事業協力
    • その他の動き

第14章 企業プロファイル

  • イントロダクション
  • SARTORIUS STEDIM BIOTECH S.A.
  • MERCK MILLIPORE
  • GE HEALTHCARE
  • DANAHER CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • PARKER HANNIFIN CORPORATION
  • APPLIKON BIOTECHNOLOGY
  • CELLEXUS LIMITED
  • CELLTAINER BIOTECH BV
  • PBS BIOTECH, INC.

第15章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2863

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016-2021). In this report, the single-use bioreactors market is broadly segmented on the basis of product type, cell type, technology, application, end user, and region. Factors such as improved return on investment for small companies and startups, reduced complexity in automation, and positive impact on the environment are driving the growth of the single-use bioreactors market.

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect and plant cells). In 2016, the monoclonal antibodies segment is expected to account for the largest share of the single-use bioreactors market. Factors such as reduced risk of contamination and easy implementation in bioproduction are driving the adoption of SUBs for the production of these molecules. Based on technology, the single-use bioreactors market is categorized into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and others technologies. The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages offered by this technology such as high flexibility and shorter lead times.

Europe is expected to account for the largest share of the single-use bioreactors market in 2016. Patent cliff of many biologics drugs in Europe and government support for pharmaceutical companies to launch new biologics therapies with superior efficacy are driving the growth of the single-use bioreactors market in this region. The APAC single-use bioreactors market is expected to register the highest CAGR of 23.4% in the next five years. The rapidly growing healthcare industry and increasing investments by major pharmaceutical companies in this region are contributing to the high growth of the APAC single-use bioreactors market during the forecast period.

Product launches was the most widely adopted growth strategy pursued by players in the single-use bioreactors market, to increase their shares and cater to the unmet needs. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the single-use bioreactors market. The report provides an analysis of the single-use bioreactors market, by product type, cell type, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the single-use bioreactors market
  • Market Development: Comprehensive information about lucrative emerging markets. This report provides an analysis of the single-use bioreactors market across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global single-use bioreactors market
  • Competitive Assessment: In-depth assessment of market strategies, product portfolios, and manufacturing capabilities of the leading players in the global single-use bioreactors market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. SINGLE-USE BIOREACTORS: MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL ANALYSIS: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE (2016)
  • 4.3. SINGLE-USE BIOREACTORS MARKET, BY END USER
  • 4.4. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE SINGLE-USE BIOREACTORS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of SUBs among small companies and startups
      • 5.2.1.2. Reduced automation complexity
      • 5.2.1.3. Ease in cultivation of marine organisms (ALGAE)
      • 5.2.1.4. Reduced environmental impact
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Regulatory concerns related to SUBs
      • 5.2.2.2. Issues regarding leachables and extractables
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing biologics market
      • 5.2.3.2. Patent expiry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Limitations in flexible bioreactors
      • 5.2.4.2. Need for improved single-use sensors

6. INDUSTRY INSIGHTS

  • 6.1. INDUSTRY INSIGHTS
  • 6.2. SUPPLY CHAIN ANALYSIS
  • 6.3. PESTEL ANALYSIS
    • 6.3.1. POLITICAL FACTORS
    • 6.3.2. ECONOMIC FACTORS
    • 6.3.3. SOCIAL FACTORS
    • 6.3.4. TECHNOLOGICAL FACTORS
    • 6.3.5. ENVIRONMENTAL FACTORS
    • 6.3.6. LEGAL FACTORS

7. SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE

  • 7.1. INTRODUCTION
  • 7.2. MONOCLONAL ANTIBODIES (MABS)
  • 7.3. VACCINES
  • 7.4. RECOMBINANT PROTEINS
  • 7.5. STEM CELLS
  • 7.6. GENE-MODIFIED CELLS
  • 7.7. OTHER PRODUCTS

8. SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL

  • 8.1. INTRODUCTION
  • 8.2. MAMMALIAN CELLS
  • 8.3. BACTERIAL CELLS
  • 8.4. YEAST CELLS
  • 8.5. OTHER CELLS

9. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS
  • 9.3. STIRRED SINGLE-USE BIOREACTORS
  • 9.4. SINGLE-USE BUBBLE COLUMN BIOREACTORS
  • 9.5. OTHER TECHNOLOGIES

10. SINGLE-USE BIOREACTORS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. BIOPRODUCTION
  • 10.3. PROCESS DEVELOPMENT
  • 10.4. RESEARCH & DEVELOPMENT

11. GLOBAL SINGLE-USE BIOREACTORS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. BIOPHARMACEUTICAL MANUFACTURERS
  • 11.3. R&D DEPARTMENTS

12. GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S.
    • 12.2.2. CANADA
  • 12.3. EUROPE
    • 12.3.1. U.K.
    • 12.3.2. GERMANY
    • 12.3.3. REST OF EUROPE (ROE)
  • 12.4. ASIA-PACIFIC
  • 12.5. REST OF THE WORLD (ROW)

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. COMPETITIVE SITUATION AND TRENDS
    • 13.2.1. PRODUCT LAUNCHES
    • 13.2.2. ACQUISITIONS
    • 13.2.3. COLLABORATIONS
    • 13.2.4. OTHERS

14. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*

  • 14.1. INTRODUCTION
  • 14.2. SARTORIUS STEDIM BIOTECH S.A.
  • 14.3. MERCK MILLIPORE
  • 14.4. GE HEALTHCARE
  • 14.5. DANAHER CORPORATION
  • 14.6. THERMO FISHER SCIENTIFIC, INC.
  • 14.7. PARKER HANNIFIN CORPORATION
  • 14.8. APPLIKON BIOTECHNOLOGY
  • 14.9. CELLEXUS LIMITED
  • 14.10. CELLTAINER BIOTECH BV
  • 14.11. PBS BIOTECH, INC.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. OTHER DEVELOPMENTS
  • 15.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.6. AVAILABLE CUSTOMIZATIONS
  • 15.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
  • TABLE 2: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 73: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 74: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 75: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 76: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 78: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 79: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 82: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 89: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 90: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 92: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 94: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 95: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 96: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 97: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 99: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 100: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 101: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 104: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 105: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 109: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 110: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 112: PRODUCT LAUNCHES, 2013-2016
  • TABLE 113: ACQUISITIONS, 2013-2016
  • TABLE 114: COLLABORATIONS, 2013-2016
  • TABLE 115: OTHERS, 2013 TO 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: SINGLE-USE BIOREACTOR MARKET: TOP DOWN APPROACH
  • FIGURE 3: SINGLE-USE BIOREACTOR MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: SINGLE-USE BIOREACTORS MARKET SIZE, BY CELL TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT: SINGLE-USE BIOREACTORS MARKET
  • FIGURE 12: RISING FOCUS ON REDUCING OPERATIONAL COSTS-A PRIMARY GROWTH DRIVER OF THE SINGLE-USE BIOREACTORS MARKET
  • FIGURE 13: MAMMALIAN CELLS TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 14: BIOPHARMACEUTICAL MANUFACTURERS WILL CONTINUE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET IN 2021
  • FIGURE 15: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS ARE PROJECTED TO BE THE FASTEST-GROWING TECHNOLOGY SEGMENT DURING FORECAST PERIOD
  • FIGURE 16: APAC WILL BE THE FASTEST-GROWING REGIONAL MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: GLOBAL SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: U.S.: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
  • FIGURE 19: SUPPLY CHAIN: SINGLE-USE BIOREACTORS MARKET
  • FIGURE 20: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOREACTORS MARKET IN 2016
  • FIGURE 21: U.K. TO BE THE FASTEST-GROWING SEGMENT OF THE SINGLE-USE BIOREACTORS MARKET FOR MABS
  • FIGURE 22: EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOREACTORS MARKET FOR RECOMBINANT PROTEINS IN 2016
  • FIGURE 23: U.S. TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET FOR GENE-MODIFIED CELLS IN 2016
  • FIGURE 24: ASIA-PACIFIC TO BE THE FASTEST GROWING SEGMENT OF SINGLE-USE BIOREACTORS MARKET FOR OTHER PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 25: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL (2016-2021)
  • FIGURE 26: EUROPE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SUBS MARKET FOR BACTERIAL CELLS IN 2016
  • FIGURE 27: THE U.K. IS EXPECTED TO BE THE FASTEST-GROWING COUNTRY IN THE EUROPEAN SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS DURING THE FORECAST PERIOD
  • FIGURE 28: WAVE-INDUCED MOTION SUBS ARE PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 29: EUROPE TO DOMINATE THE STIRRED SINGLE-USE BIOREACTORS TECHNOLOGY SEGMENT IN 2016
  • FIGURE 30: THE U.K. IS EXPECTED TO BE THE FASTEST-GROWING COUNTRY IN THE EUROPEAN SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET DURING THE FORECAST PERIOD
  • FIGURE 31: BIOPRODUCTION TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 32: U.S. TO DOMINATE THE NORTH AMERICAN MARKET FOR PROCESS DEVELOPMENT
  • FIGURE 33: EUROPE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET FOR R&D DURING THE FORECAST PERIOD
  • FIGURE 34: BIOPHARMACEUTICAL MANUFACTURERS FORM THE LARGEST END-USER SEGMENT OF THE SINGLE-USE BIOREACTORS MARKET
  • FIGURE 35: EUROPE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET FOR BIOPHARMACEUTICAL MANUFACTURERS DURING THE FORECAST PERIOD
  • FIGURE 36: GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 37: MAMMALIAN CELLS SEGMENT WILL WITNESS HIGH GROWTH IN THE NORTH AMERICAN AND ASIA-PACIFIC MARKETS
  • FIGURE 38: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 39: R&D SEGMENT TO GROW AT THE HIGHEST RATE IN THE NORTH AMERICAN SINGLE-USE BIOREACTORS APPLICATIONS MARKET
  • FIGURE 40: BIOPHARMACEUTICAL MANUFACTURERS SEGMENT TO DOMINATE THE U.S. SINGLE-USE BIOREACTORS MARKET, BY END USER
  • FIGURE 41: EUROPE: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 42: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE
  • FIGURE 43: WAVE-INDUCED MOTION SUB TO DOMINATE THE U.K. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
  • FIGURE 44: R&D DEPARTMENTS TO WITNESS THE HIGHEST GROWTH IN THE SINGLE-USE BIOREACTORS END-USERS MARKET IN GERMANY
  • FIGURE 45: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE
  • FIGURE 46: WAVE-INDUCED MOTION SUB TO DOMINATE THE ROW SINGLE-USE BIOREACTORS MARKET, BY APPLICATION
  • FIGURE 47: PRODUCT LAUNCHES WAS THE MOST WIDELY ADOPTED GROWTH STRATEGY BY MARKET PLAYERS BETWEEN 2013 & 2016
  • FIGURE 48: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL GROWTH STRATEGIES ADOPTED BY PLAYERS BETWEEN 2013 & 2016
  • FIGURE 49: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 50: COMPANY SNAPSHOT: SARTORIUS STEDIM BIOTECH S.A.
  • FIGURE 51: COMPANY SNAPSHOT: MERCK MILLIPORE
  • FIGURE 52: COMPANY SNAPSHOT: GE HEALTHCARE
  • FIGURE 53: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 54: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 55: COMPANY SNAPSHOT: PARKER HANNIFIN CORPORATION
Back to Top